NRX Pharmaceuticals (NRXP) Receivables - Net (2020 - 2026)

NRX Pharmaceuticals (NRXP) has 6 years of Receivables - Net data on file, last reported at $362000.0 in Q1 2026.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $362000.0 in Q1 2026; TTM through Mar 2026 was $362000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $161000.0, changed N/A from the prior year.
• Receivables - Net for Q1 2026 stood at $362000.0, up from $161000.0 in the prior quarter.
• Over the last five years, Receivables - Net for NRXP reached as high as $362000.0 in Q1 2026 and fell as low as $6000.0 in Q1 2023.
• Historically, Receivables - Net has averaged $118000.0 across 5 years, with a median of $6000.0 in 2023.
• Across the five-year window, Receivables - Net sank 97.78% in 2023 and changed 0.0% in 2024, its largest moves.
• Year by year, Receivables - Net stood at $270000.0 in 2022, then sank by 97.78% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then surged by 2583.33% to $161000.0 in 2025, then soared by 124.84% to $362000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $362000.0 in Q1 2026, $161000.0 in Q4 2025, and $239000.0 in Q3 2025.